AdvanSix Reports Q3 2026 Results with Increased Sales Amidst EBITDA Decline
AdvanSix (ASIX) reported third-quarter sales of $431 million, a 15% increase year-over-year driven by significant pricing improvements across all product lines. Despite the revenue growth, the company faced a decline in Adjusted EBITDA to $15 million, down from the previous year, due to reduced production output and rising raw material costs. The company also reported an adjusted diluted loss per share of $0.24. Operational highlights include a 33% surge in Nylon Resin sales and strong performance in Chemical Intermediates. While volume for caprolactam declined due to soft construction demand, the company successfully managed cash flow, reporting $48 million in operating cash flow and $30 million in free cash flow. Looking ahead, AdvanSix is focusing on its Project CENTURY modernization program and a multiyear cost-reduction initiative.
Tickers: $ASIX
Topics: cash flow earnings report EBITDA decline EPS loss revenue growth